Estradiol replacement elevates the serum and tissue levels of α-tocopherol in ovariectomized rats

Journal of Nutritional Biochemistry

Volumn 9, Issue 2, 1998, Pages 67-74

  Chung, Hae Jung ^a   Koo, Sung I ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Estrogen; High density lipoprotein; Ovariectomy; Phospholipid; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; ESTRADIOL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; NONHUMAN; OVARIECTOMY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE LEVEL; VITAMIN BLOOD LEVEL;

EID: 0032006141     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(97)00168-X     Document Type: Article

References (52)

1. 1 Snzajderman, M. and Oliver, M.F. (1963). Spontaneous premature menopause, ischemic heart disease, and serum lipids. Lancet 1, 962-965
2. 2 Kannel, W.B., Hjortland, M.C., McNamara, P.M., and Gordon T. (1976). Menopause and risk of cardiovascular disease. The Framingham Study. Ann. Intern. Med. 85, 447-452
3. 3 Gordon, T., Kannel, W.B., Hjortland, M.C. and McNamara, P.M. (1978). Menopause and coronary heart disease, The Framingham Study. Ann. Intern. Med. 89, 157-161
4. 4 Rosenberg, L., Hennekens, C.H., Rosner, B., Belanger, C., Rothman, K.J. and Speizer, F.E. (1981). Early menopause and the risk of myocardial infarction. Am. J. Obstet. Gynecol. 139, 47-51
5. 5 Miller, V.T. (1994). Lipids, lipoproteins, women and cardiovascular disease. Atherosclerosis 108, S73-S82
6. 6 Samaan, S.A. and Crawford, M.H. (1995). Estrogen and cardiovascular function after menopause. J. Am. Coll. Cardiol. 26, 1403-1410
7. 7 Bush, T.L., Barret-Connor, E., Cowan, L.D., Criqui, M.H., Wallace, R.B., Suchindran, C.M., Tyroler, H.A., and Rifkind, B.M. (1987). Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics program follow-up study. Circulation 75, 1102-1109
8. 8 Stampfer, M.J. and Colditz, G.A. (1991). Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Preventive Med. 20, 47-63
9. 9 Schaefer, E.J., Foster, D.M., Zech, L.A., Lindgren, F.T., Brewer, H.B. and Levy, R.I. (1983). The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J. Clin. Endocrinol. Metab. 57, 262-267.
10. 10 Fahraeus, L. and Wallentin, L. (1983). High density lipoprotein subtractions during oral cutaneous administration 17beta-estradiol to menopausal women. J. Clin. Endocrinol. Metab. 56, 797-801
11. 11 Hazzard, W.R., Haffner, S.M., Kushwaha, R.S., and Applebaum-Bowden, D. (1984). Preliminary report: Kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman. Metabolism 33, 779-784
12. 12 Sharf, M., Oettinger, M.S., Lanir, A., Kahana, L., and Yeshurun, D. (1985). Lipid and lipoprotein levels following pure estradiol implantation in postmenopausal women. Gynecol. Obstet. Invest. 19, 207-212.
13. 13 Barret-Connor, E. and Bush, T.L. (1991). Estrogen and coronary heart disease in women. JAMA 265, 1861-1867
14. 14 Bush, T.L. and Barret-Connor, E. (1985). Noncontraceptive estrogen use and cardiovascular disease. Epidemiol. Rev. 7, 80-104
15. 15 Yagi, K. and Komura, S. (1986). Inhibitory effect of female hormones on lipid peroxidation. Biochem. Int. 13, 1051-1055
16. 16 Nakano, M., Sugioka, K., Naito, I., Takekoshi, S., and Niki, E. (1987). Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol. Biochim. Biophys. Res. Comm. 142, 919-924
17. 17 Lacort, M., Leal, A.M., Lisa M., Martin, C., Martinez, R., and Ruiz-Larrea, M.B. (1995). Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lipids 30, 141-146
18. 18 Mukai, K., Daifuku, K., Yokoyama, S., and Nakano, M. (1990). Stopped-flow investigation of antioxidant activity of estrogens in solution. Biochim. Biophys. Acta 1035, 348-352
19. 19 Rifici, V. and Khachadurian, A.K. (1992). The inhibition of low density lipoprotein oxidation by 17β-estradiol. Metabolism 41, 1110-1114
20. 20 Subbiah, R., Kessel, B., Agrawal, M., Rajan, R., Abplanalp, W., and Rymaszewski, Z. (1993). Antioxidant potential of specific estrogens on lipid peroxidation. J. Clin. Endocrinol. Metab. 77, 1095-1097
21. 21 Sack, M.N., Rader, D.J., and Cannon, R.O. (1994). Oestrogen and inhibition of oxidation of low density lipoproteins in postmenopausal women. Lancet 343, 269-270
22. 22 Tang, M., Abplanalp, W., Ayres, S., and Subbiah, R. (1996). Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism 45, 411-414
23. 23 Steinberg, D. (1991). Antioxidants and atherosclerosis: A current assessment. Circulation 84, 1420-1425
24. 24 Esterbauer, H., Rotheneder, M.D., Striegl, G., and Waeg, G. (1991). Role of vitamin E in preventing the oxidation of low density lipoprotein. Am. J. Clin. Nutr. 53, 314S-321S
25. 25 Princen, H.M.G., von Poppel, G., Vogelezang, C., Buytenhek, R., and Kok, F.J. (1992). Supplementation with vitamin E but not with β-carotene in vivo protects low density lipoprotein from peroxidation: effect of cigarette smoking. Arterioscler. Thromb. 12, 554-562
26. 26 Suzukawa, M., Ishikawa, T., Yoshida, H., and Nakamura, H. (1995). Effect of in vivo supplementation with low dose vitamin E on susceptibility of low density lipoprotein and high density lipoprotein to oxidative modification. J. Am. Coll. Nutr. 14, 46-52
27. 27 Stampfer, M. and Rimm, E.B. (1995). Epidemiologic evidence for vitamin E in prevention of cardiovascular disease. Am. J. Clin. Nutr. 62, 1365S-1369S
28. 28 Thomas, S.R., Neuzil, J., Mohr, D. and Stocker, R. (1995). Coantioxidants make α-tocopherol an efficient antioxidant for low density lipoprotein. Am. J. Clin. Nutr. 62, 1357S-1364S
29. 29 Kayden, H.J. and Traber, M.G. (1993). Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res. 34, 343-358
30. 30 Koo, S.I., Chung, H.J and Noh, S.K. (1997). The lymphatic absorption and biliary secretion of α-tocopherol (αTP) and serum HDL αTP are markedly increased by estradiol replacement in ovariectomized rats. The 16th International Congress of Nutrition, Abstracts, p. 117
31. 31 Reeves, P.G., Nielsen, F.H., and Fahey, G.C. (1993). AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123, 1939-1951
32. 32 Yang L., Koo, S.I., and Jeon, I. (1996). The lymphatic absorption of fatty acids and output of phospholipid are lowered by estrogen replacement in ovariectomized rats. J. Nutr. Biochem. 7, 274-221
33. 33 Bentzen, C.L., Acuff, K.J., Marechal, B., Rosenthal, M.A., and Volk, M.E. (1982). Direct determination of lipoprotein cholesterol distribution with micro-scale affinity chromatography columns. Clin. Chem. 28, 1451-1456
34. 34 Folch, J., Lees, M., and Sloane-Stanley, G.H. (1957). A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509
35. 35 Liu, J.-F. and Huang, C.-J. (1995). Tissue α-tocopherol retention in male rats is compromised by feeding diets containing oxidized frying oil. J. Nutr. 125, 3071-3080
36. 36 Raheja, R.K., Kaur, C., Singh, A., and Bhatia, I.S. (1973). New colorimetric method for the quantitative estimation of phospholipids without acid digestion. J. Lipid Res. 14, 695-697
37. 37 SAS Institute Inc. SAS User's Guide: Statistics, Version 5. SAS Institute, Cary, NC, USA
38. 38 Bjorneboe, A., Bjorneboe, G-E. A., Bodd, E., Hagen, B.F., Kveseth, N. and Drevon, C.A. (1986). Transport and distribution of α-tocopherol in lymph, serum and liver cells in rats. Biochim. Biophys. Acta 889, 310-315
39. 39 Noh, S.K. and Koo, S.I. (1997). The lymphatic absorption of lipids is normalized by enteral phosphatidylcholine infusion in ovariectomized rats with estrogen replacement. J. Nutr. Biochem. 8, 152-161
40. 40 Hassager, C. and Christiansen, C. (1989). Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women. Metabolism 38, 662-665
41. 41 Haarbo, J., Maraslew, U., Gotfredsen, A., and Christiansen, C. (1991). Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40, 1323-1326
42. 42 Dunn, J.F., Nisula, B.C., and Rodbard, D. (1981). Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J. Clin. Endocrinol. Metab. 53, 58-68
43. 43 Leszczynski, D.E. and Schafer, R.M. (1990). Nonspecific and metabolic interactions between steroid hormones and human plasma lipoproteins. Lipids 25, 711-718
44. 44 Leszczynski, D.E. and Schafer, R.M. (1991). Metabolic conversion of six steroid hormones by human plasma high density lipoprotein. Biochim. Biophys. Acta 1083, 18-28
45. 45 Behrens, W.A. and Madere, R. (1985). Transport of α- and τ-tocopherol in human plasma lipoproteins. Nutr. Res. 5, 167-174
46. 46 Traber, M.G. and Kayden, H.J. (1984). Vitamin E is delivered to cells via the high affinity receptor for low density lipoprotein. Am. J. Clin. Nutr. 40, 747-751
47. 3H]α-tocopherol from low density lipoprotein by cultured human fibroblasts. J. Nutr. 115, 1673-1679
48. 48 Bowry, V.W., Stanley, K.K. and Stocker, R. (1992). High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. USA 89, 10316-10320
49. 49 Nagano, Y., Arai, H. and Kita, T. (1991). High density lipoprotein loses its effect to stimulate cholesterol efflux from foam cells after oxidative modification. Proc. Natl. Acad. Sci. USA 88, 6457-6461
50. 50 Bonnefont-Rousselot, D., Motta, C., Khalil, A.O., Sola, R., La Vile, A.E., Delatte, J., and Gardes, A.M. (1995). Physicochemical changes in human high density lipoproteins oxidized by gamma radiolysis-generated oxyradicals. Effect on their cholesterol effluxing capacity. Biochim. Biophys. Acta 1255, 23-30
51. 51 Traber, M.G., Lane, J.C., Lagmay, N.R., and Kayden, H.J. (1992). Studies on the transfer of tocopherol between lipoproteins. Lipids 27, 657-663
52. 52 Parthasarathy, S. Barnett, J., and Fong, L.G. (1990). High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta 1044, 275-283